title: Changes in cytosolic and membrane TNF inhibitory protein-B1 (TIP-B1) levels associated with protection from TNF-induced cytotoxicity.
authors.affiliation: Department of Pharmacology and Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
authors.forename: A D
authors.initials: AD
authors.lastname: Henn
authors.forename: E S
authors.initials: ES
authors.lastname: Berleth
authors.forename: E
authors.initials: E
authors.lastname: Mihich
authors.forename: M J
authors.initials: MJ
authors.lastname: Ehrke
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D002458:Cell Fractionation; D003513:Cycloheximide / Q000494:pharmacology; D020405:Dermis / Q000166:cytology; D005347:Fibroblasts / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D015151:Immunoblotting; D047908:Intracellular Signaling Peptides and Proteins; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011506:Proteins / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D047908:Intracellular Signaling Peptides and Proteins; D011500:Protein Synthesis Inhibitors; D011506:Proteins; C400565:SH3BGRL3 protein, human; D014409:Tumor Necrosis Factor-alpha; D003513:Cycloheximide